These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20117844)

  • 1. MGAT5 alters the severity of multiple sclerosis.
    Brynedal B; Wojcik J; Esposito F; Debailleul V; Yaouanq J; Martinelli-Boneschi F; Edan G; Comi G; Hillert J; Abderrahim H
    J Neuroimmunol; 2010 Mar; 220(1-2):120-4. PubMed ID: 20117844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGAT5 and disease severity in progressive multiple sclerosis.
    Esposito F; Wojcik J; Rodegher M; Radaelli M; Moiola L; Ghezzi A; Capra R; Brambilla P; Sorosina M; Giacalone G; Martinelli V; Comi G; Abderrahim H; Martinelli Boneschi F
    J Neuroimmunol; 2011 Jan; 230(1-2):143-7. PubMed ID: 21115203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism at codon 129 of the prion protein gene is not associated with multiple sclerosis.
    Stüve O; Korth C; Gabatto P; Cameron EM; Hu W; Eagar TN; Monson NL; Frohman EM; Racke MK; Zabetian CP; Oksenberg JR
    Arch Neurol; 2009 Feb; 66(2):280-1. PubMed ID: 19204171
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
    Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
    J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE epsilon4 is associated with impaired verbal learning in patients with MS.
    Koutsis G; Panas M; Giogkaraki E; Potagas C; Karadima G; Sfagos C; Vassilopoulos D
    Neurology; 2007 Feb; 68(8):546-9. PubMed ID: 17310023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia.
    Djurić T; Zivković M; Stanković A; Dincić E; Raicević R; Alavantić D
    J Neurol Sci; 2008 Apr; 267(1-2):62-5. PubMed ID: 17942123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?
    Brynedal B; Khademi M; Wallström E; Hillert J; Olsson T; Duvefelt K
    Neurobiol Dis; 2010 Mar; 37(3):613-21. PubMed ID: 19944761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
    Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR
    Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.
    Galimberti D; Scalabrini D; Fenoglio C; De Riz M; Comi C; Venturelli E; Cortini F; Piola M; Leone M; Dianzani U; D'Alfonso S; Monaco F; Bresolin N; Scarpini E
    J Neurol Sci; 2008 Apr; 267(1-2):86-90. PubMed ID: 17967467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism.
    Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A
    Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MS and cognition and APOE: the ongoing conundrum about biomarkers.
    Sadovnick AD; Jacobs DH
    Neurology; 2008 Jan; 70(3):164-5. PubMed ID: 18195261
    [No Abstract]   [Full Text] [Related]  

  • 13. KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis.
    Goris A; Dobosi R; Boonen S; Nagels G; Dubois B
    J Neuroimmunol; 2009 May; 210(1-2):113-5. PubMed ID: 19304328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population.
    Dincić E; Zivković M; Stanković A; Obradović D; Alavantić D; Kostić V; Raicević R
    J Neuroimmunol; 2006 Aug; 177(1-2):146-50. PubMed ID: 16769128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the UNC13A gene as a risk factor for sporadic amyotrophic lateral sclerosis.
    Daoud H; Belzil V; Desjarlais A; Camu W; Dion PA; Rouleau GA
    Arch Neurol; 2010 Apr; 67(4):516-7. PubMed ID: 20385924
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of pyridoxal kinase and Parkinson disease.
    Vilariño-Güell C; Wider C; Aasly JO; White LR; Rajput A; Rajput AH; Lynch T; Krygowska-Wajs A; Jasinska-Myga B; Opala G; Barcikowska M; Czyzewski K; Wu RM; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
    Ann Neurol; 2010 Mar; 67(3):409-11. PubMed ID: 20373354
    [No Abstract]   [Full Text] [Related]  

  • 17. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.
    Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH
    Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.
    Cavanillas ML; Fernández O; Comabella M; Alcina A; Fedetz M; Izquierdo G; Lucas M; Cénit MC; Arroyo R; Vandenbroeck K; Alloza I; García-Barcina M; Antigüedad A; Leyva L; Gómez CL; Olascoaga J; Otaegui D; Blanco Y; Saiz A; Montalbán X; Matesanz F; Urcelay E
    Genes Immun; 2011 Mar; 12(2):110-5. PubMed ID: 20944657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
    Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.